TCL Archive Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares. April 23, 2004
TCL Archive OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB October 13, 1989
TCL Archive Preliminary Report Tends To Support Pill’s Association With Liver Tumors November 19, 1976
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light December 5, 2014
